Assessment of the condition of pro-/antioxidant systems in the rats heart of different age with hypogonadism


  • Volkova Yu. V. SI «Institute of Children and Adolescents Health Care of the NAMS of Ukraine», Kharkiv, Ukraine
  • Sukhova L. L. SI «Institute of Children and Adolescents Health Care of the NAMS of Ukraine», Kharkiv, Ukraine



hypoandrogenism, testosterone, heart, rats


A specific androgen receptor is present in cardiomyocytes. Тhis proves the role of androgens in the work of the heart. Hypoandrogenia can be one of the conditions for changing the intensity of the processes of radical formation and the activity of the antioxidant system in the cells of the heart. Such changes may cause metabolic disorders and may increase the risk of developing and progressing pathological changes in the cardiovascular system. The age characteristics of the oxidative balance in the heart of different ages rats are determined. It is proved, that the influence of hypoandrogenism on the state of pro- / antioxidant systems in the heart of rats is age-dependent. It was found that the condition of androgen deficiency is more reflected on the oxidative balance of the heart of early sexual maturity rats. It has been established that hypoandrogenism is accompanied by modulation of the state of pro- / antioxidant balance in the heart of 3-months-old animals. This leads to the formation of oxidative stress. At the same time, in the heart of 2-months-old rats, under conditions of hypoandrogenism, there are significant changes in the intensity of the processes of free radical oxidation of proteins and lipids, as well as the activity of antioxidant defense enzymes. does not occur due to the fact that the rats in this age have increased basal indicators of redox-balance. It is suggested that testosterone in the heart of pubertal rats is not a key factor in the processes of regulation of the oxidative balance, where as in early sexual maturity age, its properties change towards the antioxidant effect. 


Kolesnikova LI, Kurashova NA, Grebenkina LA, et al. Bjul VSNC SO RAMN 2013; 4 (92): 136-140.

Zhang Li, Wu S, Ruan Y, et al. Mol Med Reports 2011;4: 1183-1188.

Malkin CJ, Pugh PJ, West JN, et al. Eur Heart J 2006;27: 57-64. doi:

Li ZB, Wang J, Wang JX, et al. Zhanghua Nan Ke Xue 2009; 15: 994-1000.

Békési G, Kakucs R, Várbíró S, et al. Steroids 2000; 65: 889-894. doi:

Alonso Alvarez C, Bertrand S, Faivre B, et al. Proc Biol Sci 2007; 274: 819-825. doi:

Ray R, Murdoch CE, Wang M, et al. Arterioscler Thromb Vasc Biol 2011; 31: 1368-1376. doi:

Puttabyatappa Y, Stallone JN, Ergul A, et al. J Pharmacol Exp Ther 2013; 345: 7-14. doi:

Gurer B, Kertmen H, Kasim E, et al. Injury 2015; 46: 240-248.

Martorell A, Blanco-Rivero J, Aras-Lopez R, et al. Cardiovasc Res 2008; 77: 590-599. doi:

Lopes RA, Neves KB, Pestana CR, et al. Am J Physiol Heart Circ Physiol 2014; 306: H1485-H1494. doi:

Barton M, Prossnitz ER, Meyer MR. Hypertension 2012;59: 1101-1103. doi:

Klapcinska B, Jagsz S, Sadowska-Krepa E, et al. J Physiol Sci 2008; 58: 173-177. doi:

Mancini A, Leone E, Festa R, et al. J Androl 2008;29: 622-629. doi:

Tostes RC, Carneiro FS, Carvalho MHC, Reckelhoff JF. Am J Physiol Regul Integr Comp Physiol 2016; 310: R1-R14. doi:

Gladkova AI. Andrologicheskie projavlenija stressa, Har’kov, 2013: 268 p.

Toledo-Rodriguez M, Sandi C. Neural Plast 2007; 2007: 71203. doi:

Romeo RD, McEwen BC. Ann NY Acad Sci 2006; 1094: 226-234.

Zhao G, Mo J, Zheng T, et al. Reprod Toxicol 2018; 83: 8-13.




How to Cite

Volkova, Y. V. ., & Sukhova, L. L. . (2021). Assessment of the condition of pro-/antioxidant systems in the rats heart of different age with hypogonadism. Problems of Endocrine Pathology, 67(1), 79-86.